NASDAQ: LAB · Medical Devices
Over the past week, Standard BioTools (LAB) logged about 150 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 19% bullish but is sharply divided: X runs 37% bullish while News sits at just 0%. Wall Street is more constructive, with 1 of 2 analysts rating LAB a buy.
There is little buzz around LAB this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 50% buy share sits next to a crowd that ranges from News at 0% to X at 37%. No other tracker puts the two side by side.
2 analysts have weighed in: a Buy consensus: 1 buy call against 0 sell, with an average 12-month price target of $1.35.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 2 sources disagree sharply, so the read is a Sell.
Analysts sit 31 points above the crowd average of 19%, the professionals are more constructive than retail. The split is inside the crowd: X reads 37% bullish while News sits at 0%, a 37-point spread that single-source trackers miss.
Over the 30-day window, Standard BioTools (LAB) buzz held subdued around 32.3 while the price drifted down 20.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.6M shares. Updated Aug 15, 2026. Over the last 7 trading days, LAB lost 11.0%. Buzz activity in the recent week averaged 50.5 and was highly volatile, swinging between 32.3 and 79.9. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 8 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for LAB and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live LAB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Buy (1 / 1 / 0) |
| Crowd bullish (7d) | 19% |
| Avg price target | $1.35 |
| Most bullish source | X, 37% |
| Most bearish source | News, 0% |
| Sentiment spread | 37 pts |
| Mentions (7d) | 150 |
| Market cap | $294.4M |
| EPS · Beta | -$0.12 · 1.4 |
| Revenue (TTM) | $84.6M · 100% margin |
| Industry | Medical Devices |
Based on aggregated sentiment from X and News sources, Standard BioTools (LAB) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 19% bullish across 2 active sources. Those sources contribute 150 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bearish on Standard BioTools (LAB), averaging 19% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 37% bullish and News at 0%, a 37-point spread. On the professional side, 1 of 2 analysts rate LAB a buy.
Of the 2 analysts covering Standard BioTools (LAB), 1 rate it a buy, 1 a hold and 0 a sell, for a buy consensus. The average price target is $1.35. That puts the street ahead of the crowd, which averages 19% bullish.
Standard BioTools (LAB)'s cross-source average is bearish at 19% bullish. All 2 tracked sources lean bearish. X reads 37% bullish and news coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Standard BioTools (LAB) at 19% bullish. All 2 tracked sources lean bearish. The most bearish reading is news at 0% bullish. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 150 mentions (100% of total volume). The cross-source average is bearish at 19% bullish. All 2 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. LAB's sell signal at 93/100 conviction reflects a bearish cross-source average at 19% bullish. All 2 tracked sources lean bearish. It is a research shortcut, not financial advice.
The LAB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key